Your browser doesn't support javascript.
loading
The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses.
Deng, Jun; Chen, Qian; Chen, Zhian; Liang, Kaili; Gao, Xin; Wang, Xiaohui; Makota, Fadzai V; Ong, Hong Sheng; Wan, Yanmin; Luo, Kaiming; Gong, Dongcheng; Yu, Xiang; Camuglia, Sarina; Zeng, Qunxiong; Zhou, Tao; Xue, Feng; He, Jing; Wei, Yunbo; Xiao, Fan; Ma, Jianyang; Hill, Danika L; Pierson, Wim; Nguyen, Thi H O; Zhou, Haibo; Wang, Yan; Shen, Wei; Sun, Lingyun; Li, Zhanguo; Xia, Qiang; Qian, Kun; Ye, Lilin; Rockman, Steven; Linterman, Michelle A; Kedzierska, Katherine; Shen, Nan; Lu, Liwei; Yu, Di.
Affiliation
  • Deng J; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen Q; Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China.
  • Chen Z; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Liang K; Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China.
  • Gao X; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang X; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Makota FV; The University of Queensland Diamantina Institute, Translational Research Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Ong HS; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wan Y; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Luo K; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Gong D; Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China.
  • Yu X; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Camuglia S; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
  • Zeng Q; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhou T; Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xue F; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • He J; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wei Y; Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xiao F; Seqirus, Parkville, VIC, Australia.
  • Ma J; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hill DL; Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Pierson W; Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Nguyen THO; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Zhou H; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
  • Wang Y; Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China.
  • Shen W; China-Australia Centre for Personalised Immunology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Sun L; Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li Z; Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Xia Q; Lymphocyte Signaling and Development, Babraham Institute, Cambridge, UK.
  • Qian K; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.
  • Ye L; Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Rockman S; Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Linterman MA; Department of Laboratory Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Kedzierska K; Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Shen N; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Lu L; Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yu D; School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Nat Commun ; 12(1): 3073, 2021 05 24.
Article in En | MEDLINE | ID: mdl-34031386

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Leptin / Antibody Formation Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Leptin / Antibody Formation Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country: Country of publication: